Avvaa World Health Care Products Inc (AVVH)

[Scuba J]

Vernon, BC - August 9, 2010— avVaa World Health Care Products Inc. (“the Company”) (Pink Sheets: AVVH) announces that it has filed its interim financial statements and the associated Management’s Discussion and Analysis for the quarters ending August 31, 2009, November 30, 2009, and February 28, 2010.

These documents may be viewed on SEDAR at www.sedar.com or on the Company’s website at www.avvaa.com. However, the Company will provide a copy of any such document, free of charge, to any security holder of the Company who requests them.

The Company is diligently working on completing the remaining required continuous disclosure documents in order to have the Cease Trade Order revoked.

About avVaaWorld Health Care Products
avVaa is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC Neuroskin® line of skin care products through mass food and drug channels in the United States and globally. The Company's secondary line of equine and pet care related products are already being distributed throughout all of Canada. For more information, visit www.avvaa.com or contact Merle Goertz, Public Relations, at 1-866-864-6598 Ext. 705.

For further information, please contact:

Lance Loose, CEO
avVaa World Health Care Products Inc
P: 1-866-864-6598
www.avvaa.com

http://www.tradingmarkets.com/news/stock-alert/avvh_avvaa-files-2010-interim-financials-1098228.html